VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
112 hedge funds and large institutions have $36.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 42 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 26
Holders
112
Holding in Top 10
–
Calls
$146K
Puts
$2K
Top Buyers
| 1 | +$76K | |
| 2 | +$69.4K | |
| 3 | +$65.5K | |
| 4 |
E
Ergoteles
New York
|
+$57.6K |
| 5 |
JPMorgan Chase & Co
New York
|
+$52.9K |
Top Sellers
| 1 | -$441K | |
| 2 | -$322K | |
| 3 | -$319K | |
| 4 |
Millennium Management
New York
|
-$285K |
| 5 |
State Street
Boston,
Massachusetts
|
-$276K |